Clinical Leadership | FairMed × SPMD clinical collaboration

Built with physicians in sports medicine

FairMed is developed with clinical knowledge from members of the Panamanian Society of Sports Medicine (SPMD). Decision frameworks, substance interpretations and AUT/TUE pathways are shaped with physician input and cross-checked against the official WADA documents — as decision support, not as a validating authority.

Medical Board

Active physicians with real clinical practice in sports medicine, intensive care, cardiology training and university teaching — not marketing figures. Additional SPMD contributors will be published as their authorizations are confirmed.

Dr. Mauricio Beitia Kraemer

President, SPMD · Clinical Director, FairMed

MD, MSc · Sports Medicine, Intensive Care, Cardiology training

🏛

Universidade São Francisco — Bragança Paulista, Brazil · Faculty

🏥

MK CardioSport — Personal clinical practice (Brazil & Panama)

🩺

Clinical practice — sports medicine, critical care, cardiovascular training for athletes

SPMD Vice-Presidency · Pulmonology

SPMD board member joining the clinical knowledge & development panel — profile publication pending physician authorization.

Coordinator-General · SPMD

Profile publication pending — biographical data and credentials to be added by the SPMD secretariat.

Clinical Reviewer · Radiology / Imaging

SPMD-affiliated radiologist joining the clinical knowledge & development panel — profile publication pending.

Clinical knowledge & development partner: SPMD

The Panamanian Society of Sports Medicine (medsportpanama.com) contributes clinical knowledge to the development of FairMed's anti-doping decision support. SPMD's physicians help shape the substance database, AUT/TUE pathways and regulatory interpretations, which are cross-checked against the official WADA documents. FairMed is a decision-support tool, not a validating authority; independent accuracy validation is a planned next step.

Disclosure: Dr. Mauricio Beitia Kraemer is concurrently founder of FairMed and President of SPMD. He discloses both roles openly and abstains from SPMD's internal votes that concern FairMed, to keep the two roles separate.

How clinical review works

FairMed's development pipeline is straightforward, auditable and limited in scope — we don't replace authorities, we support decisions.

🔎

Physician-developed content

Clinical decision frameworks, substance classifications and documentation checklists are developed with SPMD physicians and cross-checked against the official WADA documents before publication.

🗂

Source-linked

Every rule, threshold and route-dependent decision cites the specific WADA standard (Code, ISTUE, ISL, ISTI, ISRM) or peer-reviewed reference.

🔔

Regulatory watch

FairMed monitors the official WADA document pages weekly and notifies clinical leadership when standards are updated or new versions are published.

⚖️

Non-authoritative by design

FairMed does not grant AUT/TUE, does not issue sanctions, does not override official decisions. Final clinical and anti-doping judgment remains with the treating physician and the competent authority.

Institutional statement

FairMed is an independent project founded and operated by Dr. Mauricio Beitia Kraemer, MD, MSc, developed with clinical knowledge and co-development in collaboration with the Sociedad Panameña de Medicina del Deporte (SPMD) — medsportpanama.com. The platform serves athletes, physicians, clinics, federations, Olympic committees and telemedicine programs across Latin America and beyond — with content in English, Spanish and Portuguese.

Institutional contracts and invoicing are coordinated directly during the sales conversation. Clinical development is kept separate from commercial decisions.

Contact for institutional inquiries, research collaboration or SPMD partnership: join the Global Antidoping Clinical Network.